20:21 , Feb 2, 2018 |  BC Week In Review  |  Company News

Shire licenses recombinant immunoglobulin from AB Biosciences

AB Biosciences Inc. (Allston, Mass.) granted Shire plc (LSE:SHP; NASDAQ:SHPG) exclusive, worldwide rights to develop and commercialize its pan receptor interacting molecule (PRIM) program. PRIM is a recombinant immunoglobulin that AB Biosciences said has shown...
00:38 , Jan 31, 2018 |  BC Extra  |  Company News

Shire licenses recombinant immunoglobulin from AB Biosciences

AB Biosciences Inc. (Allston, Mass.) granted Shire plc (LSE:SHP; NASDAQ:SHPG) exclusive, worldwide rights to develop and commercialize its pan receptor interacting molecule (PRIM) program. PRIM is a recombinant immunoglobulin that AB Biosciences said has shown...